Tryp Therapeutics Inc (TRYP.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 08-2022 | 05-2022 | 02-2022 | 11-2021 | 08-2021 | |
| Operating Expenses | 2,104 | 701 | 1,549 | 3,010 | 2,752 |
| Operating Income | -2,104 | -701 | -1,549 | -3,010 | -2,752 |
| Other Income | -65 | -49 | -10 | 9 | -18 |
| Pre-tax Income | -2,170 | -750 | -1,559 | -3,001 | -2,770 |
| Net Income Continuous | -2,170 | -750 | -1,559 | -3,001 | -2,770 |
| Net Income | $-2,170 | $-750 | $-1,559 | $-3,001 | $-2,770 |
| EPS Basic Total Ops | -0.03 | -0.01 | -0.03 | -0.05 | -0.04 |
| EPS Basic Continuous Ops | -0.03 | -0.01 | -0.03 | -0.05 | -0.04 |
| EPS Diluted Total Ops | -0.03 | -0.01 | -0.03 | -0.05 | -0.04 |
| EPS Diluted Continuous Ops | -0.03 | -0.01 | -0.03 | -0.05 | -0.04 |
| EBITDA(a) | $-2,104 | $-701 | $-1,549 | $-3,010 | $-2,752 |